300009 安科生物
按盤價 
9.840 +0.040 (+0.408%)
9.840 +0.040 (+0.408%) | 2025/12 - 人民幣(K¥) | 變動 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 2,646,520 | 4.36% | 2,865,752 | 2,331,063 | 2,168,765 | 1,701,417 | |
| 減：營業總成本 | 1,835,650 | 3.07% | 1,930,498 | 1,560,199 | 1,556,413 | 1,288,618 | |
| 其中:營業成本 | 643,158 | 12.18% | 620,344 | 503,375 | 432,415 | 361,080 | |
| 財務費用 | 2,538 | -254.71% | (3,809) | (2,393) | (7,089) | (11,757) | |
| 資產減值損失 | (17,471) | 122.54% | (17,484) | (27,590) | (346,340) | (15,181) | |
| 公允價值變動收益 | 1,881 | -82.11% | (411) | 36,299 | 19,343 | 1,485 | |
| 投資收益 | 18,204 | 17.94% | (4,742) | 4,800 | 6,102 | (2,232) | |
| 其中：對聯營企業和合營企業的投資收益 | (17,159) | -36.81% | (31,707) | (20,430) | (17,377) | (14,512) | |
| 營業利潤 | 836,961 | 3.79% | 923,979 | 841,994 | 297,438 | 424,042 | |
| 利潤總額 | 833,158 | 3.75% | 919,930 | 833,848 | 295,117 | 416,139 | |
| 減：所得稅費用 | 85,819 | -1.56% | 61,341 | 96,192 | 91,731 | 69,604 | |
| 淨利潤 | 747,339 | 4.40% | 858,589 | 737,656 | 203,386 | 346,535 | |
| 減：非控股權益 | 12,146 | 36.63% | 11,360 | 34,396 | (3,243) | (12,421) | |
| 股東淨利潤 | 735,193 | 4.00% | 847,229 | 703,260 | 206,629 | 358,955 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.440 | 4.76% | 0.510 | 0.430 | 0.130 | 0.220 | |
| 每股派息 (元) * | 0.250 | 0.00% | 0.250 | 0.250 | 0.200 | 0.200 | |
| 每股淨資產 (元) * | 2.725 | 10.52% | 2.229 | 1.918 | 1.701 | 2.077 | |
| 審計意見 # | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 10/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
